Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients
NCT01377467
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Osteoporosis
Chronic Kidney Disease
Interventions
DRUG:
Denosumab (Prolia)
Sponsor
Rudolf Wuethrich